Nintedanib
Has a Manageable Safety Profile
AEs
(any grade) that were
more common
with
nintedanib:
Gastrointestinal events
Diarrhoea
,
nausea and vomiting
Manageable
with supportive treatment and
dose modification
Liver enzyme evaluation (ALT/AST)
Reversible
upon dose modification
